Bio-Path Holdings, Inc. (BPTH) financial statements (2020 and earlier)

Company profile

Business Address 4710 BELLAIRE BOULEVARD
BELLAIRE, TX 77401
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments151699144
Cash and cash equivalents151699144
Inventory, net of allowances, customer advances and progress billings      0
Inventory      0
Prepaid expense1010   
Other current assets1101000
Other undisclosed current assets    10 
Total current assets:17271110144
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment001100 
Intangible assets, net (including goodwill)  11111
Intangible assets, net (excluding goodwill)  11111
Total noncurrent assets:1012111
TOTAL ASSETS:18291211155
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1111100
Accounts payable1100000
Accrued liabilities1011100
Debt0      
Due to related parties     00
Deferred revenue and credits 0   
Other undisclosed current liabilities     00
Total current liabilities:1111110
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Liabilities, other than long-term debt   3   
Derivative instruments and hedges, liabilities   3   
Total noncurrent liabilities:0  3   
Total liabilities:2114110
Stockholders' equity
Stockholders' equity attributable to parent, including:1618810155
Common stock0000000
Additional paid in capital70494740353520
Accumulated deficit(54)(48)(39)(32)(25)  
Other undisclosed stockholders' equity attributable to parent     (20)(15)
Total stockholders' equity:1618810155
TOTAL LIABILITIES AND EQUITY:18291211155

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues  00   
Cost of revenue
(Cost of Goods and Services Sold)
     (0)(0)
Gross profit:  00 (0)(0)
Operating expenses(8)(9)(9)(8)(5)(5)(3)
Other undisclosed operating income     00
Operating loss:(8)(9)(9)(8)(5)(5)(3)
Nonoperating income0022000
Investment income, nonoperating0000000
Other nonoperating expense     (0)(0)
Interest and debt expense  (0)    
Loss from continuing operations before equity method investments, income taxes:(8)(9)(7)(7)(5)(5)(3)
Other undisclosed income from continuing operations before income taxes  0    
Loss from continuing operations before income taxes:(8)(9)(7)(7)(5)(5)(3)
Income tax expense (benefit) (0)0  (0) 
Other undisclosed loss from continuing operations(0)      
Net loss:(8)(9)(7)(7)(5)(5)(3)
Other undisclosed net income (loss) attributable to parent00(0)  0 
Net loss attributable to parent:(8)(9)(7)(7)(5)(5)(3)
Preferred stock dividends and other adjustments  (1)    
Net loss available to common stockholders, diluted:(8)(9)(8)(7)(5)(5)(3)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(8)(9)(7)(7)(5)(5)(3)
Comprehensive loss, net of tax, attributable to parent:(8)(9)(7)(7)(5)(5)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: